1887

Abstract

Use of viral inducible promoters which can be activated by virus-specific transactivator proteins to drive expression of antisense (as)RNA genes appears to be an attractive approach to inhibit virus infections . To this end, we have constructed an asRNA gene expressed from the bovine leukaemia virus (BLV) U3 promoter that is complementary to the R-U5 region of the BLV genome. This is the region that is most susceptible to inhibition by asRNA. With plasmid pLU, which expresses the asRNA gene under the control of the BLV U3 promoter, 75 % inhibition of virus replication was attained in CC81 cells (the molar ratio of pLU DNA over BLV proviral DNA in the transfection mixture was 5:1). Plasmid pLT, which contains only the BLV U3 promoter without any asRNA-coding region, also efficiently (up to 60%) inhibited virus replication when cotransfected with BLV proviral DNA at a ratio of 20:1. It was suggested that competition between functional and ‘empty’ viral promoters for the viral transactivator protein p38 could account for this inhibition. An immunoblotting assay showed that in the presence of nuclear extracts from CC81 cells exogenous BLV p38 specifically associates with its responsive sequence located in the BLV U3 promoter. Moreover, the additional expression of p38 in CC81 cells abolishes the inhibitory effect of the empty viral promoter. These observations suggest a new mechanism of BLV inhibition caused, most probably, by sequestering of the viral transactivator protein.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-78-8-1941
1997-08-01
2022-05-23
Loading full text...

Full text loading...

/deliver/fulltext/jgv/78/8/9266992.html?itemId=/content/journal/jgv/10.1099/0022-1317-78-8-1941&mimeType=html&fmt=ahah

References

  1. Ausubel F. M., Breut R., Kingston R. E., Moore D. D., Seidman J. G., Smith J. A., Struhl K. 1991 Current Protocols in Molecular Biology New York: John Wiley;
    [Google Scholar]
  2. Baurin V., Miroshnichenko O. I., Zakharchenko V. I., Prokofiev M. I., Ernst L. K., Tikchonenko T. I. 1995; Transgenic rabbits with the asRNA against the RU5 LTR region of bovine leukemia virus. In Bioengineering Farm Animals Part 1 pp 154–165 Moscow: In Russian
    [Google Scholar]
  3. Borisenko A. S., Miroshnichenko O. I., Tikchonenko T. I. 1992; Inhibition of bovine leukaemia virus replication by the antisense RNA in cell line CC81. Virus Research 23:89–97
    [Google Scholar]
  4. Colbere-Garapin F., Horodniceanu F., Kourilsky Ph., Garapin A. -G. 1981; A new dominant hybrid selective marker for higher eucaryotic cells. Journal of Molecular Biology 150:1–14
    [Google Scholar]
  5. Coleman J., Hirashima A., Inokuchi Y., Green P. J., Inouye M. 1985; A novel immune system against bacteriophage infection by using anti-sense RNA (mic RNA). Nature 315:601–603
    [Google Scholar]
  6. Cotten M., Birnstiel M. L. 1989; Ribozyme mediated destruction of RNA in vivo. EMBO Journal 8:3861–3866
    [Google Scholar]
  7. Derse D. 1988; Trans-acting regulation of bovine leukemia virus mRNA processing. Journal of Virology 61:1115–1119
    [Google Scholar]
  8. Ferrer J. F., Cabradilla C., Gupta P. 1981; Use of a feline cell line in the syncytia infectivity assay for detection of bovine leukemia virus infection in cattle. American Journal of Veterinary Research 42:9–14
    [Google Scholar]
  9. Graham F., van der Eb A. J. 1973; A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52:456–467
    [Google Scholar]
  10. Hirai H., Fujisawa J., Suzuki T., Ueda K., Muramatsu M., Tsuboi A., Arai N., Yoshida M. 1992; Transcriptional activator Tax of HTLV- I binds to NF-kappa B precursor p105. Oncogene 7:1737–1742
    [Google Scholar]
  11. Innis M. I., Gelfant D. H., Sninsky J. J., White T. J. 1990 PCR Protocols: A Guide to Methods and Applications San Diego: Academic Press;
    [Google Scholar]
  12. Itohara S., Sekikawa K. 1987; Molecular cloning of infectious proviral genomes of bovine leukemia virus. Virology 159:158–160
    [Google Scholar]
  13. Itohara S., Tomiyama T., Ushimi C., Sekikawa K. 1988; Cooperative regulation of bovine leukemia virus gene expression by two overlapping open reading frames in the XBL region. Journal of General Virology 69:797–804
    [Google Scholar]
  14. Kakidani H., Watarai S., Onuma M., Tomochika K., Yasuda T. 1993; Suppressive effect of liposomes containing DNA coding for diphtheria toxin A-chain on cells transformed with bovine leukemia virus. Microbiology and Immunology 37:713–720
    [Google Scholar]
  15. Katoh I., Yoshinaka Y., Sagata N., Ikawa Y. 1987; The bovine leukemia virus X region encodes a trans-activator of its long terminal repeat. Japanese Journal of Cancer Research 78:93–98
    [Google Scholar]
  16. Katoh I., Yoshinaka Y., Ikawa Y. 1989; Bovine leukemia virus transactivator p38tax activates heterologous promoters with a common sequence known as a cAMP-responsive element or the binding site of a cellular transcription factor ATF. EMBO Journal 8: 497–503
    [Google Scholar]
  17. Kiss-Toth E., Paca-Uccaralertkun S., Unk I., Boros I. 1993; Members of the CREB/ATF protein family, but not CREB alpha play an active role in BLV tax trans-action in vivo. Nucleic Acids Research 21:3677–3682
    [Google Scholar]
  18. Kozireva S., Konicheva V., Murovska M., Baurin V., Shayakhmetov D., Ernst L., Prokofiev M., Tikchonenko T. 1996; Investigation of an antisense RNA gene effect on the reproduction ofthe bovine leukemia virus in vivo. Transgenics 2:99–109
    [Google Scholar]
  19. Marriott S. J., Boros I., Duvall J. F., Brady J. N. 1989; Indirect binding of human T-cell leukemia virus type I tax to a responsive element in the viral long terminal repeat. Molecular and Cellular Biology 9:4152–4160
    [Google Scholar]
  20. Miroshnichenko O. I., Borisenko A. S., Ponomareva T. I., Tikchonenko T. I. 1990; Inhibition of adenovirus replication by the E1A antisense transcript initiated from hsp70 and VA-1 promoters. Biomedical Science 1:267–273
    [Google Scholar]
  21. Orita S., Sato S., Aono Y., Minoura N., Yamashita T., Hinuma Y., Igarashi H. 1993; Identification of novel singly spliced pX mRNA transcripts common to all human T-cell leukemia virus type 1-related retroviruses. Virus Genes 7:197–204
    [Google Scholar]
  22. Powers M. A., Radke K. 1992; Activation of bovine leukemia virus transcription in lymphocytes from infected sheep: rapid transition through early to late gene expression. Journal of Virology 66: 4769–4777
    [Google Scholar]
  23. Rhodes A., James W. 1990; Inhibition of human immunodeficiency virus replication in cell culture by endogenously synthesized antisense RNA. Journal of General Virology 71:1965–1974
    [Google Scholar]
  24. Sagata N., Yasunaga T., Tsuzuku-Kawamura J., Ohishi K., Ogawa Y., Ikawa Y. 1985; Complete nucleotide sequence of the genome of bovine leukemia virus : its evolutionary relationship to other retroviruses. Proceedings of the National Academy of Sciences USA: 82677–681
    [Google Scholar]
  25. Sambrook J., Fritsch E. F., Maniatis T. 1989; . Molecular Cloning: A Laboratory Manual, 2nd edn.. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory;
    [Google Scholar]
  26. Takayama K. M., Kuriyama S., Weiss S., Chada K., Inouye S., Inouye M. 1989; Antisense RNA-mediated inhibition of viral infection in tissue culture and transgenic mice. In Molecular Biology of RNA pp 299–310 New York: Alan R. Liss;
    [Google Scholar]
  27. Tikchonenko T. I. 1991; Antisense polynucleotides as factor of informational immunity. In Biotechnology on the Threshold of XXI Century pp 68–71 Mascow: Russian Academy of Sciences;
    [Google Scholar]
  28. Wang S. J., Dolnick B. J. 1993; Quantitative evaluation of intracellular sense-antisense RNA hybrid duplexes. Nucleic Acids Research 21:4383–4391
    [Google Scholar]
  29. Willems L., Gegonne A., Chen G., Burny A., Kettmann R., Ghysdael J. 1987; The bovine leukemia virus p34 is a transactivator protein. EMBO Journal 6:3385–3389
    [Google Scholar]
  30. Willems L., Kettmann R., Chen G., Portetelle D., Burny A., Derse D. 1992; A cyclic AMP-responsive DNA-binding protein (CREB2) is a cellular transactivator of bovine leukemia virus long terminal repeat. Journal of Virology 66:766–772
    [Google Scholar]
  31. Zhao L. -J., Giam C. -Z. 1992; Human T-cell lymphotropic virus type I (HTLV-I) transcriptional activator Tax enhances CREB binding to HTLV-I 21-base-pair repeats by protein-protein interaction. Proceedings of the National Academy of Sciences USA: 897070–7074
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-78-8-1941
Loading
/content/journal/jgv/10.1099/0022-1317-78-8-1941
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error